Pharynx cancer
MONDO:0005517A primary or metastatic malignant neoplasm that affects the pharynx.
Also known as: pharynx neoplasm, cancer of chordate pharynx, cancer of pharynx, chordate pharynx cancer, malignant chordate pharynx neoplasm, malignant neoplasm of chordate pharynx, malignant neoplasm of pharynx, malignant pharyngeal neoplasm
3425 clinical trials for this condition and its sub-types, 10 tagged with Pharynx cancer itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
Sub-types of Pharynx cancer
-
Oropharynx cancer 150 trials · 280 incl. sub-types
4 sub-types
- Oropharyngeal carcinoma 100 trials · 243 incl. sub-types Sub-types →
- Waldeyer's ring cancer 0 trials · 8 incl. sub-types Sub-types →
- Soft palate cancer 0 trials · 1 incl. sub-types Sub-types →
- Vallecula cancer 0 trials
-
Malignant tumor of nasopharynx 9 trials · 214 incl. sub-types
1 sub-type
- Nasopharyngeal carcinoma 211 trials · 212 incl. sub-types Sub-types →
-
Pharyngeal squamous cell carcinoma 5 trials · 203 incl. sub-types
2 sub-types
- Oropharynx squamous cell carcinoma 192 trials · 195 incl. sub-types Sub-types →
- Hypopharynx squamous cell carcinoma 65 trials
-
Hypopharynx cancer 50 trials · 100 incl. sub-types
4 sub-types
- Hypopharyngeal carcinoma 36 trials · 86 incl. sub-types Sub-types →
- Postcricoid region cancer 1 trial
- Pyriform sinus cancer 1 trial
- Aryepiglottic fold cancer 0 trials
-
Pharyngeal adenoid cystic carcinoma 0 trials
Most studied deeper sub-types
-
New cocktail of cancer drugs tested in desperate cases
Disease control Stopped earlyThis early-phase trial tested combinations of the drugs bevacizumab and temsirolimus, sometimes with valproic acid or cetuximab, in 154 people with advanced cancers or certain non-cancerous but progressive diseases. The main goal was to find safe doses and look for any signs that…
Phase 1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
Immune cell therapy tested for tough childhood cancers
Disease control Stopped earlyThis early-phase study tested a treatment using donated natural killer (NK) cells from cord blood, combined with chemotherapy, for children and young adults with solid tumors that returned or didn't respond to standard care. The goal was to find the safest dose and check for side…
Phase 1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC